TXCELL
7Patents
5Active
7Granted
38Portfolio score
Filing activity: Jun 24, 2004 → Oct 7, 2011 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8722401B2 | In vitro production of a cell population using feeder cells | Chemistry; Metallurgy | 6 | Active |
| US7771932B1 | Method for identification of Tr1 lymphocytes regulators by the presence and over-expression of specific molecules and application thereof | Chemistry; Metallurgy | 5 | Expired |
| US7977093B2 | Obtention of food- or auto-antigen specific TR1 cells from a leukocyte or PBMC population | Chemistry; Metallurgy | 1 | Active |
| US8815534B2 | Method for assessing the efficacy of a TR1 cell therapy in a subject | Physics | 0 | Active |
| US7985409B2 | Tr1 cells for use in atherosclerosis | Chemistry; Metallurgy | 0 | Expired |
| US8992907B2 | Compositions for treating an intestinal inflammatory condition | Chemistry; Metallurgy | 0 | Active |
| US9517253B2 | Compositions for treating multiple sclerosis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.